A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
PHASE2
The IMPACT Long Covid Treatment clinical study (IMPACT-LC) is testing two r...
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
PHASE3
The purpose of this study is to assess whether maraviroc administered once ...
Status
Terminated
Location
University of Alabama at Birmingham - 1917 Research Clinic
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects
PHASE2
Maraviroc (UK-427,857), a selective and reversible CCR5 co-receptor antagon...